About CAPILLARYS 3 OCTA
The CAPILLARYS 3 OCTA is the most recent Sebia automated capillary electrophoresis system.
The CAPILLARYS 3 OCTA builds on the capabilities of the CAPILLARYS 2 FLEX-PIERCING, with numerous enhancements, based on the same technology platform as the CAPILLARYS 3 TERA.
The CAPILLARYS 3 OCTA offers a broad assay menu in myeloma, diabetes, hemoglobinopathies and chronic alcohol abuse.
The CAPILLARYS 3 OCTA shares the same reagents and consumables as the other CAPILLARYS 3 instruments, allowing labs to adopt the most relevant platforms, mixing CAPILLARYS 3 OCTA, TERA, and TERA MC configurations to align with individualized needs of their organization. This flexibility and modularity also allows the lab to evolve with a scalable Sebia solution.
Key benefits
Flexible platform
CAPILLARYS 3 can run up to 7 techniques, automated technique changes are enabled via pre-set switch racks, which allows users to load up to 120 samples with diverse tests simultaneously.
Scalable solution
Sharing the same technical platform and reagent line, laboratories can combine different CAPILLARYS 3 platforms to meet their individual needs in production capacity, in addition to the large automated capillary electrophoresis menu.
Smart reagent management
4 open positions for main reagents, temperature-controlled section for secondary reagent (antisera), automated reagent identification, change buffers without interrupting testing.
Advanced piloting Software
Delivered with each Sebia’s instrument, the PHORESIS software allows a laboratory to manage instrument results providing a flexible solution.
Main characteristics
- Serum Protein Electrophoresis (SPE)
- Serum Immunotyping
- Urine Protein Electrophoresis (UPE)
- Urine Immunotyping
- Hb A1c (venous blood & capillary blood)
- Hemoglobin Electrophoresis (adult blood)
- CDT & CDTIFCC
Sample types: whole blood, urine, serum
With 8 capillaries, the CAPILLARYS 3 OCTA reduces hands-on-time and offers a large loading capacity with 120 samples (15 racks).
Throughput (tests/hour)*
PROTEIN(E) 6 (serum) 79
PROTEIN(E) 6 (urine) 70
IMMUNOTYPING (serum or urine) 9
Hb A1c 43
HEMOGLOBIN(E) 45
CDT 49
* Using Software version 9.30
- 4 flexible positions for reagents > optimize your on-board reagent strategy
- Reload reagents without halting specimen analysis > generate results without interruption
- RFID identification for all reagents (reagent type, lot number, expiration date, volume) > comprehensive traceability throughout workflow
- Reagent cups automatically loaded
- Embedded user interface with intuitive touch screen
- Automatic technique change
- Automatic start-up and shut-down
- Visual alarms (with instrument notifications)
- Dedicated workstation to pilot the instrument and manage results
- Sample racks with 8 RFID identified positions
- Direct sampling from primary tubes
- Automatic mixing and cap-piercing for whole blood samples
- Flexible waste management options (on-board or external)
- CAPILLARYS 3 OCTA – P/N: 1245
Featured tests for CAPILLARYS 3 OCTA
See all testsSerum Protein by Capillary Electrophoresis
High throughput Serum Protein Electrophoresis with high resolution results.
Urine Protein by Capillary Electrophoresis
High throughput Urine Protein Electrophoresis, with high resolution results.
Serum and Urine Immunotyping
Fully automated monoclonal proteins identification by Capillarys electrophoresis.
Hemoglobin disorders screening
The high-resolution method for hemoglobin disorders screening.
Carbohydrate Deficient Transferrin (CDT)
The most reliable chronic alcohol abuse marker.
Related resources
See all resourcesThe simple principles of innovative Capillary electrophoresis testing
Understand in 2 minutes how capillary electrophoresis works, and why it gives such high and clear resolution in lab testing.
TAT reduction with solution integration
Understand your needs and constraints to provide you with the most suitable and integrated solution.
Interview with M. Jean Deenmamode, CDT IFCC Working Group Chair
Interview between Sebia and M. Jean Deenmamode, CDT IFCC Working Group Chair
HbA1c – The Hidden Factors
HbA1c is routinely used in the clinical laboratory to diagnose and monitor diabetes mellitus. Many methods have been standardized to provide precise and accurate results for normal patients. For the other common Hb variants, most of the methods are now relatively free of analytical interference.
Multiple Myeloma clinical cases for diagnosis and monitoring according to latest IMWG recommendations
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
Early detection of Multiple Myeloma: The importance of serum protein electrophoresis
Educational Webinar with Dr. Julien GUILLEMAUD
Clinical and Operational Aspects of Measuring Hemoglobin A1c by Capillary Electrophoresis
Educational Webinar with David G. Grenache, PhD, D(ABCC)
Chief Scientific Officer, TriCore Reference Laboratories
Moving from Immunofixation to Immunotyping Improves Standard of Care by Hand-on and Turnaround Time
Learn how a Sebia customer gained both clinically and operationally with a simplified IT workflow.
Hemoglobinopathy Testing: What are the Key Points a Lab Should Consider?
Educational Webinar Dr. Cornelia L. Harteveld from Leiden University Medical Center
Challenges in Implementing Capillary Electrophoresis for Immunotyping
Educational Webinar with Dr. Jack Maggiore from Loyola University Medical Center in Chicago, IL
Hemoglobinopathy Investigation – The Case for Capillary Electrophoresis
Educational Webinar with Jason EYRE
Discover the main applications related to the CDT marker
CDT is a sensitive and specific marker of chronic alcohol abuse, used in several contexts and notably including forensic settings, industries, clinical applications.
Sebia USA Learning Series
Sebia specializes in providing testing solutions for a range of diseases, including Diabetes and Multiple Myeloma. Learn about the impact of these diseases and the medical solutions available.
How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis
Educational Webinar with Dr. Barbara De la Salle
Scientific publications
See all publicationsEurA1c trial
The EurA1c trial, organized yearly, investigates the performance of HbA1c assays across countries and manufacturers.
Further evaluation of the world health organization international reference reagent for Haemoglobin A2 measurement
This article assesses the performances of the different manufacturers and technologies (HPLC and CE) for Hb A2 measurement using both International Reference Reagent for HbA2 (WHO IRR 89/666) and analysis of three whole blood specimens over a range of HbA2, distributed to 56 laboratories located in 14 different countries.
Effects of hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by twelve methods
Hemoglobin C, D Punjab, E or S trait can interfere with hemoglobin A1c (HbA1c) results depending on the method of analysis used. Therefore, it is important to know the limitations of the method used for HbA1c determination.
Carbohydrate-deficient transferring testing: a truly traceable and specific biomarker for chronic alcohol misuse
Article from Jean Deenmamode, IFCC CDT working group chair in CLI magazine.
International standardization of CDT measurement
IFCC CDT-Working Group standardized the CDT measurement.
Interested in CAPILLARYS 3 OCTA?
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.